We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Neutropenia febril y pancitopenia aguda en pacientes con leucemia linfoide aguda posterior a consolidación con metotrexato en el Centro Javeriano de Oncología durante el periodo 2012-2014.
- Authors
CÓRDOBA NÚÑEZ, MARÍA ADELAIDA; GUZMÁN CRUZ, PAULA CAROLINA; AZUERO, SILVIA ACERO
- Abstract
Introduction: Acute lymphocytic leukemia (ALL) is the most common childhood malignancy. Treatment includes 3 phases. During the cosolidation phase the use of methrotexate in different doses, depending on the risk classification, is the treatments main pilar. Objective: To Estimate the presence of febrile neutropenia, anemia and thrombocytopenia in patients with ALL receiving methotrexate during the consolidation phase at a dose of 5 g/m² compared to patients who received doses of 2 g/m². Methods: Review clinical records of all patients between 1 and 15 years old treated for ALL at the Oncology Center of Javeriana University between January 1/2012 and March 10/2014. Results: Information of 66 cycles of chemotherapy were collected, of which 31 corresponded to 2 g/m² and 35 to 5 g/m² applications. The frequency of febrile neutropenia in the group 2 g/m² was 25 % and 34 % in the group 5 g/m², which resembles literature reports. Conclusion: The use of high-dose of methotrexate for the management of ALL in our area did not represent an increase in haematological toxicity compared to low dose group. And there is enough evidence of improved cure rates of the disease.
- Subjects
CHEMOTHERAPY complications; LYMPHOBLASTIC leukemia in children; METHOTREXATE; FEBRILE neutropenia; THROMBOCYTOPENIA in children; ANEMIA in children; DRUG side effects; LEUKEMIA treatment
- Publication
Universitas Médica, 2014, Vol 55, Issue 4, p383
- ISSN
0041-9095
- Publication type
Article